or
forgot password

    • cancer clinical trials in buffalo, NY

    • Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
    Roswell Park Cancer Institute - Infectious Diseases
    Buffalo, New York 14263-0001
    Bacterial Infection
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Neuroblastoma
    Bio-Behavioral Lung Cancer Prevention Program
    State University of New York
    Buffalo, New York 14203-1154
    Smoking Cessation
    Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lymphoma, Non-Hodgkin, Multiple Myeloma
    The Second Multicenter Hemophilia Cohort Study
    University of Buffalo
    Buffalo, New York
    Liver Decompensation, Hepatocellular Carcinoma, Non-Hodgkin Lymphoma
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Veterans Affairs Medical Center - Buffalo
    Buffalo, New York 14215
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma
    A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma
    Experience of Having Chronic Graft-Versus-Host Disease
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Graft-Versus-Host Disease
    A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
    Site Ref # / Investigator 3569
    Buffalo, New York 14215
    Lung Cancer, Non-Small Cell Lung Cancer
    Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
    Hemophilia Center of Western New York
    Buffalo, New York 14215
    Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Gaucher Disease, Non-Neuronopathic Form
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Bacterial Infections
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Cytomegalovirus Infections
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Bruce L. Platt, Md

    Trial Locations
    Bruce L. Platt, Md
    Buffalo Heart Group, Llp
    Atrial Fibrillation, Atrial Flutter
    A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic
    Phase I/II Study of hLL1 in Multiple Myeloma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA
    Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Myelodysplastic Syndromes, Secondary Myelodysplastic Syndromes
    Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lung Cancer
    Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Colorectal Cancer
    Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Pancreatic Cancer
    Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma
    Department of Dermatology, Roswell Park Cancer Institue
    Buffalo, New York 14263
    Basal Cell Carcinoma
    A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589
    Novartis Investigative Site
    Buffalo, New York 14263
    Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Leukemia
    Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Cutaneous T-Cell Lymphoma
    Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Lymphoblastic Leukemia (ALL)
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Myeloid Leukemia
    Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
    Site Reference ID/Investigator# 5652
    Buffalo, New York 14263
    Non-Small Cell Lung Cancer (NSCLC)
    Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Precancerous/Nonmalignant Condition
    Vitamin D in Treating Patients With Prostate Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Prostate Cancer
    Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Esophageal Cancer, Gastric Cancer, Liver Cancer
    Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest Surgery
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Pain, Perioperative/Postoperative Complications
    Combination of GTI 2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Myeloid Leukemia
    Message Framing for Telephone Quitline Callers
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Smoking, Nicotine Dependence
    Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chronic Lymphocytic Leukemia
    Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma
    Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Solid Tumors
    Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients
    Roswell Park Cancer
    Buffalo, New York 14263
    Advanced Cancer
    A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
    State University of New York
    Buffalo, New York 14203-1154
    Refractory Myasthenia Gravis
    A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Pancreatic Neoplasms
    Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chronic Lymphocytic Leukemia (CLL)
    Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
    Kaleida Health/Diabetes Center of WNY
    Buffalo, New York 14206
    Acromegaly
    KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific